BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guo F, Zhao X, Gill T, Zhou Y, Campagna M, Wang L, Liu F, Zhang P, DiPaolo L, Du Y, Xu X, Jiang D, Wei L, Cuconati A, Block TM, Guo JT, Chang J. An interferon-beta promoter reporter assay for high throughput identification of compounds against multiple RNA viruses. Antiviral Res 2014;107:56-65. [PMID: 24792753 DOI: 10.1016/j.antiviral.2014.04.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Lee SB, Park YH, Chungu K, Woo SJ, Han ST, Choi HJ, Rengaraj D, Han JY. Targeted Knockout of MDA5 and TLR3 in the DF-1 Chicken Fibroblast Cell Line Impairs Innate Immune Response Against RNA Ligands. Front Immunol 2020;11:678. [PMID: 32425931 DOI: 10.3389/fimmu.2020.00678] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Guo F, Wu S, Julander J, Ma J, Zhang X, Kulp J, Cuconati A, Block TM, Du Y, Guo JT, Chang J. A Novel Benzodiazepine Compound Inhibits Yellow Fever Virus Infection by Specifically Targeting NS4B Protein. J Virol 2016;90:10774-88. [PMID: 27654301 DOI: 10.1128/JVI.01253-16] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
3 Zhao X, Zheng S, Chen D, Zheng M, Li X, Li G, Lin H, Chang J, Zeng H, Guo JT. LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2. J Virol 2020;94:e00562-20. [PMID: 32641482 DOI: 10.1128/JVI.00562-20] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
4 Park SJ, Kim J, Kang S, Cha HJ, Shin H, Park J, Jang YS, Woo JS, Won C, Min DH. Discovery of direct-acting antiviral agents with a graphene-based fluorescent nanosensor. Sci Adv 2020;6:eaaz8201. [PMID: 32523995 DOI: 10.1126/sciadv.aaz8201] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
5 Gage ZO, Vasou A, Gray DW, Randall RE, Adamson CS. Identification of Novel Inhibitors of the Type I Interferon Induction Pathway Using Cell-Based High-Throughput Screening. J Biomol Screen 2016;21:978-88. [PMID: 27358388 DOI: 10.1177/1087057116656314] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
6 Ma J, Zhang X, Soloveva V, Warren T, Guo F, Wu S, Lu H, Guo J, Su Q, Shen H, Solon E, Comunale MA, Mehta A, Guo JT, Bavari S, Du Y, Block TM, Chang J. Enhancing the antiviral potency of ER α-glucosidase inhibitor IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo. Antiviral Res 2018;150:112-22. [PMID: 29253498 DOI: 10.1016/j.antiviral.2017.12.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
7 Pryke KM, Abraham J, Sali TM, Gall BJ, Archer I, Liu A, Bambina S, Baird J, Gough M, Chakhtoura M, Haddad EK, Kirby IT, Nilsen A, Streblow DN, Hirsch AJ, Smith JL, DeFilippis VR. A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue Viruses. mBio 2017;8:e00452-17. [PMID: 28465426 DOI: 10.1128/mBio.00452-17] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
8 Zhang H, Zhao J, Bai X, Zhang L, Fan S, Hu B, Liu H, Zhang D, Xu S, Yan X. Cloning and expression of mink (Neovison vison) interferon-γ gene and development of an antiviral assay. Res Vet Sci 2015;101:93-8. [PMID: 26267097 DOI: 10.1016/j.rvsc.2015.06.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Menezes EG, Coelho-Dos-Reis JG, Cardoso LM, Lopes-Ribeiro Á, Jonathan-Gonçalves J, Porto Gonçalves MT, Cambraia RD, Soares EB, Silva LD, Peruhype-Magalhães V, Rios M, Chancey C, Teixeira-Carvalho A, Martins-Filho OA, Teixeira R. Strategies for serum chemokine/cytokine assessment as biomarkers of therapeutic response in HCV patients as a prototype to monitor immunotherapy of infectious diseases. Antiviral Res 2017;141:19-28. [PMID: 28163109 DOI: 10.1016/j.antiviral.2017.02.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
10 Gao Z, Zhang L, Ma J, Jurado A, Hong SH, Guo JT, Rice CM, MacDonald MR, Chang J. Development of antibody-based assays for high throughput discovery and mechanistic study of antiviral agents against yellow fever virus. Antiviral Res 2020;182:104907. [PMID: 32798604 DOI: 10.1016/j.antiviral.2020.104907] [Reference Citation Analysis]
11 [DOI: 10.1101/2020.04.02.021469] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Reference Citation Analysis]